Advanced Tools for Cancer Biomarker Discovery and Validation
As a gene-centric company, OriGene has developed new technologies and products for cancer biomarker discovery and validation
As a gene-centric company, OriGene has developed new technologies and products for cancer biomarker discovery and validation
Hot Topics
- BioSimilars
- KRAS
- Stem Cells
- Liver Diseases
- HSD17B
- HSD17B13
- Pancreatic Cancer
- Colorectal Cancer
- ROR
- LZTFL1
- CD47
- MAGE Family
- CD1C
- Spatial Proteomics
- LGR5
- Antibody Panels
- HTT
- MAGE-A4
Neuroscience
- Amyotrophic Lateral Sclerosis
- Huntington's Disease
- Parkinson's Disease
- Alzheimer’s Disease
- Traumatic Brain Injury (TBI)
- Astrocyte Markers
Oncology
- Cancer Biomarkers
- CD Markers
- Exosomes
- Immuno Oncology
- Extracellular Matrices
- Breast Cancer
- Cervical Cancer
- Lung Cancer
- Leukemia
- IL-6 Signaling Pathway
Virus
Immunology
- Macrophage Markers
- B cell Lineage
- Immune Checkpoint
- Regulatory T cells
- Tumor-Associated Macrophages
- Cancer Testis Antigen
- TH17
- Dendritic Cells
- Allergies / Allergic Diseases
- Cytokines